Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations - Schüpbach, M; Lohmann, E; Anheim, M; Lesage, S; Czernecki, V; Yaici, S (Mov Disord, 2007)
et al.